Oxford Medical Simulation secures £5M growth financing

The London-based healthtech company, which lets clinicians practise emergencies and difficult conversations in virtual reality, will use the capital to deepen its US footprint and accelerate AI-driven product development.

Oxford Medical Simulation has raised £5 million in growth financing from Salica Investments, the London-based investment firm formerly known as Hambro Perks. The funding will support OMS’s expansion into US health systems and academic institutions, alongside investment in AI-driven simulation scenarios, learning analytics, and workflow tooling.

OMS builds virtual reality simulation software for the healthcare sector, giving nurses, doctors, and allied health professionals a way to practise clinical scenarios, emergencies, difficult conversations, procedures, anytime and anywhere, without putting real patients at risk.

The platform runs on both VR headsets and standard screens, and pairs immersive scenarios with evidence-based feedback and performance analytics that let institutions track readiness across their entire workforce.

Founded in 2017 by clinicians, the company now works ...